| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.16B | 38.04B | 41.21B | 39.42B | 39.37B | 40.01B |
| Gross Profit | 10.99B | 10.46B | 11.28B | 10.14B | 9.82B | 8.71B |
| EBITDA | 5.29B | 4.65B | 6.31B | 5.28B | 5.31B | 4.55B |
| Net Income | 2.52B | 2.62B | 3.23B | 2.56B | 2.73B | 2.40B |
Balance Sheet | ||||||
| Total Assets | 47.25B | 50.31B | 51.31B | 48.41B | 47.84B | 46.40B |
| Cash, Cash Equivalents and Short-Term Investments | 16.50B | 17.87B | 18.67B | 17.17B | 17.22B | 17.55B |
| Total Debt | 1.37B | 1.54B | 1.41B | 1.29B | 1.52B | 1.68B |
| Total Liabilities | 9.20B | 10.02B | 9.73B | 9.55B | 10.03B | 10.41B |
| Stockholders Equity | 38.04B | 40.28B | 41.57B | 38.87B | 37.81B | 35.99B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.25B | 3.81B | 3.07B | 1.66B | 2.24B |
| Operating Cash Flow | 0.00 | 4.13B | 5.23B | 4.72B | 3.52B | 3.76B |
| Investing Cash Flow | 0.00 | 1.60B | -3.14B | -1.63B | -3.02B | -684.00M |
| Financing Cash Flow | 0.00 | -4.58B | -3.40B | -3.65B | -3.35B | -1.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥37.86B | 13.70 | ― | 4.25% | 13.45% | 19.19% | |
77 Outperform | ¥31.14B | 12.54 | ― | 4.78% | -7.10% | 6.38% | |
77 Outperform | ¥61.63B | 13.52 | ― | 1.12% | 14.84% | 7.57% | |
74 Outperform | ¥77.62B | 38.22 | ― | 2.20% | 4.75% | 164.54% | |
65 Neutral | ¥67.52B | 25.01 | 2.45% | 2.19% | 5.79% | 193.94% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |